NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-229-2003-2-PH-17 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof PH National Stage 1-2005-502092 Abandoned
NIAID E-229-2003-2-BR-04 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof BR National Stage PI0410785-3 Abandoned
NCI E-070-2005-0-US-01 Inhibitors Of Ubiquitin E1 US 60/738,242 Abandoned
NIAID E-229-2003-2-NZ-15 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof NZ National Stage 543654 Abandoned
NIAID E-043-2006-0-US-01 Improved Delivery Of DNA Vaccines Using Delayed Expression And Targeting With Novel Chimeric Viral Proteins US 60/737,896 Abandoned
NIAID E-229-2003-2-MX-14 GITR Ligand and GITR Ligand-Related Molecules and Antibodies and Uses Thereof MX National Stage PA/a/2005/012475 Abandoned
NCI E-203-2004-0-US-02 Replication-Competent Adenoviral Vectors US ORD 11/282,319 8926987 Issued PDF
NEI E-094-2003-0-PCT-02 Steroid Formulation And Methods of Treatment Using Same PCT PCT PCT/US2005/42332 Expired
NEI E-094-2003-0-EP-06 Steroid Formulation And Methods of Treatment Using Same EP National Stage 05852023.0 Abandoned
NEI E-094-2003-0-AU-04 Steroid Formulation And Methods of Treatment Using Same AU National Stage 2005306309 Abandoned
NEI E-094-2003-0-CA-05 Steroid Formulation And Methods of Treatment Using Same CA National Stage 2588433 Abandoned
NCI E-230-2006-0-US-01 Pharmaceutical Composition And Method For Regulating Abnormal Cellular Proliferation US 60/737,384 Abandoned
NCI E-223-2003-1-US-03 Potent Combinations of MRNA Transport Elements US National Stage 10/557,129 8163542 Abandoned PDF
NIEHS E-103-2000-2-US-02 New Biological Potent Analogues Of The DMT-TIC Pharmaphore And Methods Of Use US ORD 11/280,752 Abandoned
NCI E-029-2006-0-US-01 N-SUBSTITUTED INDENOISOQUINOLINES AND SYNTHESIS THEREOF US 60/736,471 Abandoned
NCI E-001-2006-0-US-01 Biomarkers Of Histone Deacetylase Inhibition US 60/735,714 Abandoned
NIA E-183-2003-0-HK-22 Method For Treating Cognitve Disorders HK National Stage 05110092.1 Abandoned
NCI E-053-1996-0-JP-13 IMMORTAL HUMAN PROSTATE EPITHELIAL CELL LINES AND CLONES AND THEIR APPLICATIONS IN THE RESEARCH AND THERAPY OF PROSTRATE CANCER JP DIV 2005-326161 Abandoned
NCI E-019-2006-0-US-01 Materials and Methods For ABCB1 Polymorphic Variant Screening, Diagnosis, and Treatment US 60/736,083 Abandoned
NIMH E-181-2005-1-US-01 Neuregulinl -stimulated cell migration US 60/735,353 Abandoned
NCI E-058-2006-0-US-01 Tymidylate Kinase Mutants and Uses Therof US 60/748,828 Abandoned
NCI E-119-2007-0-US-01 TNF-ALPHA BLOCKER TREATMENT FOR ENTEROCOLITIS ASSOCIATED WITH IMMUNOSTIMULATORY THERAPEUTIC ANTIBODY THERAPY US 60/734,963 Abandoned
NCI E-261-2005-0-US-01 C-Met Ectodomain Shedding and Malignant Potential US 60/734,993 Abandoned
NCI E-118-2007-0-US-01 Prophylaxis and treatment of entercolitis associated witih anti-CTLA-4 antibody therapy US 60/734,881 Abandoned
NHLBI E-035-2003-0-US-03 Variable Curve Catheter US National Stage 10/534,362 7918819 Issued PDF
NIAID E-115-2000-0-US-15 Attenuated Human-Bovine Chimeric Parainfluenza Virus (PIV) Vaccines US CON 11/267,296 Abandoned
NCI E-004-2005-4-EP-18 Human monoclonal antibodies against Hendra and Nipah viruses EP DIV 10180621.4 Issued
NCI E-004-2005-4-US-09 Human Monoclonal Antibodies Against Hendra And Nipah US CON 14/026,142 8858938 Issued PDF
NCI E-004-2005-4-US-07 Human Monoclonal Antibodies Against Hendra And Nipah US DIV 13/195,366 8313746 Issued PDF
NCI E-004-2005-4-AU-04 Human Monoclonal Antibodies Against Hendra And Nipah AU National Stage 2005333155 Issued
NCI E-004-2005-4-EP-03 Human Monoclonal Antibodies Against Hendra And Nipah EP National Stage 05858301.4 Issued
CC E-278-2004-0-EP-03 ACCESS SYSTEM EP National Stage 05851324.3 Issued
CC E-278-2004-0-TR-07 ACCESS SYSTEM TR EP 05851324.3 Issued
CC E-278-2004-0-FR-06 ACCESS SYSTEM FR EP 05851324.3 Issued
CC E-278-2004-0-DE-05 ACCESS SYSTEM DE EP 05851324.3 Issued
NCI E-004-2005-4-PCT-01 Human Monoclonal Antibodies Against Hendra And Nipah PCT PCT COMB PCT/US2005/040050 Expired
NCI E-072-2005-0-PCT-02 Inhibition Of Proteasome Function To Potentiate The Proapoptotic And Antitumor Activity Of Cytokines PCT PCT PCT/US2005/040060 Expired
CC E-278-2004-0-PCT-02 Electromagnetically Tracked Tissue Abalation Device PCT PCT PCT/US2005/039772 Expired
NCI E-138-2007-0-PCT-02 Methods For Preparing Cells And Viruses PCT PCT PCT/US2005/040170 Expired
NCI E-004-2005-4-US-08 Human Monoclonal Antibodies Against Hendra And Nipah US DIV 13/671,721 Abandoned
NCI E-138-2007-0-EP-04 Methods For Preparing Cells And Viruses EP National Stage 05851381.3 Abandoned
NCI E-065-2005-0-EP-04 NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS EP National Stage 05824355.1 Issued
NCI E-065-2005-0-DE-08 NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS DE EP 05824355.1 Issued
NCI E-065-2005-0-FR-09 NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS FR EP 05824355.1 Issued
NCI E-065-2005-0-GB-10 NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS GB EP 05824355.1 Issued
NCI E-065-2005-0-CA-07 NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS CA National Stage 2585091 Issued
NCI E-065-2005-0-AU-06 NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS AU National Stage 2005301957 Issued
NCI E-065-2005-0-US-03 NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS US ORD 11/266,149 7608594 Abandoned PDF
NCI E-065-2005-0-PCT-02 NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS PCT PCT PCT/US2005/039990 Expired
NIA E-108-2006-0-AR-04 Compound Useful In The Treatment Or Prevention Of Cognitive Disorders Associated With Diabetes And Associated Methods AR ORD P050104610 Abandoned